{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T05:33:36Z","timestamp":1676439216736},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":639,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/bjd.12598","type":"journal-article","created":{"date-parts":[[2013,8,21]],"date-time":"2013-08-21T07:56:39Z","timestamp":1377071799000},"page":"1319-1321","source":"Crossref","is-referenced-by-count":2,"title":["Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-\u03b1 therapy necessary?"],"prefix":"10.1093","volume":"169","author":[{"given":"C.T.","family":"Reid","sequence":"first","affiliation":[{"name":"Department of Dermatology; Saint Vincent's University Hospital; Elm Park Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Gascun","sequence":"additional","affiliation":[{"name":"National Viral Reference Laboratory; University College Dublin; Belfield Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hall","sequence":"additional","affiliation":[{"name":"National Viral Reference Laboratory; University College Dublin; Belfield Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Saint Vincent's University Hospital; Elm Park Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lally","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Saint Vincent's University Hospital; Elm Park Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Saint Vincent's University Hospital; Elm Park Dublin 4 Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"10.1111\/bjd.12598-BIB0001|bjd12598-cit-0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/eurpub\/ckr083","article-title":"Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis","volume":"22","author":"Harris","year":"2012","journal-title":"Eur J Public Health"},{"key":"10.1111\/bjd.12598-BIB0002|bjd12598-cit-0002","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2009.09505.x","article-title":"British Association of Dermatologists\u2019 guidelines for biologic interventions for psoriasis 2009","volume":"161","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12598-BIB0003|bjd12598-cit-0003","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2133.2008.08851.x","article-title":"The impact of treatment with tumour necrosis factor-\u03b1 antagonists on the course of chronic viral infections","volume":"159","author":"Domm","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12598-BIB0004|bjd12598-cit-0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2004.11.025","article-title":"Etanercept as an adjuvant to interferon and ribavirin in treatment-na\u00efve patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind placebo-controlled study","volume":"42","author":"Zein","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/bjd.12598-BIB0005|bjd12598-cit-0005","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjd.12227","article-title":"Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C","volume":"168","author":"Warren","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12598-BIB0006|bjd12598-cit-0006","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/rheumatology\/ker190","article-title":"Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review","volume":"50","author":"Brunasso","year":"2011","journal-title":"Rheumatology"},{"key":"10.1111\/bjd.12598-BIB0007|bjd12598-cit-0007","first-page":"RA337","article-title":"Apoptosis in liver disease - detection and therapeutic applications","volume":"11","author":"Ghavami","year":"2005","journal-title":"Med Sci Monit"},{"key":"10.1111\/bjd.12598-BIB0008|bjd12598-cit-0008","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/1346-8138.12112","article-title":"Profile of patients with psoriasis associated with hepatitis C virus infection","volume":"40","author":"Imafuku","year":"2013","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.12598-BIB0009|bjd12598-cit-0009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jaad.2009.03.044","article-title":"Treatment of psoriasis in patients with hepatitis C: from the medical board of the national psoriasis foundation","volume":"61","author":"Frankel","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12598-BIB0010|bjd12598-cit-0010","first-page":"645","article-title":"Tumour necrosis factor-\u03b1 antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients","volume":"164","author":"Prigano","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12598-BIB0011|bjd12598-cit-0011","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jaad.2009.07.010","article-title":"Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data","volume":"62","author":"Paradisi","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12598-BIB0012|bjd12598-cit-0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2230.2000.00655-4.x","article-title":"Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C","volume":"25","author":"Downs","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12598-BIB0013|bjd12598-cit-0013","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2230.2009.03476.x","article-title":"Etanercept as prophylactic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection","volume":"35","author":"Behnam","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12598-BIB0014|bjd12598-cit-0014","unstructured":"Royal College of General Practitioners Guidance for the prevention, testing, treatment and management of hepatitis C in primary care 1st edn 2007 www.nhs.uk\/hepatitisc\/SiteCollectionDocuments\/pdf\/the-prevention-testing-treatment-and-management-of-hep-c-in-primary-care.pdf"},{"key":"10.1111\/bjd.12598-BIB0015|bjd12598-cit-0015","volume-title":"Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme","author":"National Screening Committee, U.K.","year":"2003"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12598","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12598\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:06:45Z","timestamp":1676383605000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/169\/6\/1319\/6614966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12598","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}